Molecular Determinants of Li-Fraumeni Syndrome Associated Cancers
Molecular Determinants of Li-Fraumeni Syndrome Associated Cancers
批准号:
201953
负责人:
Malkin David D
金额:
$54.54万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2010
资助国家:
加拿大
项目状态:
已结题
起止时间:
2010-03-01 至 2015-03-01
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Li-Fraumeni syndrome (LFS) is the most common form of hereditary cancer known to predispose both children and adults to a wide spectrum of malignancies. Inherited mutations of the p53 tumor suppressor gene are the most common primary genetic event in LFS.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Developing diagnostics of patient-specific cancer risk and early-stage tumorigenesis
-
批准号:478999
-
项目类别:Operating Grants
-
资助金额:$66.04万
-
财政年份:2023
-
负责人:Malkin David D
-
依托单位:
Molecular Determinants of the Li-Fraumeni Syndrome
-
批准号:313094
-
项目类别:Operating Grants
-
资助金额:$250.93万
-
财政年份:2014
-
负责人:Malkin David D
-
依托单位:
DNA Copy Number Variation in Li-Fraumeni Syndrome
-
批准号:279978
-
项目类别:Operating Grants
-
资助金额:$78.37万
-
财政年份:2013
-
负责人:Malkin David D
-
依托单位:
Targeting the Integrin-Linked Kinase Pathway in Rhabdomyosarcoma
-
批准号:224682
-
项目类别:Operating Grants
-
资助金额:$21.51万
-
财政年份:2011
-
负责人:Malkin David D
-
依托单位:
DNA Copy Number Variation in Li-Fraumeni Syndrome
-
批准号:179254
-
项目类别:Operating Grants
-
资助金额:$56.08万
-
财政年份:2009
-
负责人:Malkin David D
-
依托单位:
海外基金